Lifevantage (NASDAQ:LFVN) Director Acquires $47,565.00 in Stock

Lifevantage Corporation (NASDAQ:LFVN) Director Judd Dayton bought 10,500 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was purchased at an average price of $4.53 per share, for a total transaction of $47,565.00. Following the completion of the transaction, the director directly owned 80,359 shares of the company’s stock, valued at $364,026.27. This represents a 15.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.

Judd Dayton also recently made the following trade(s):

• On Friday, February 27th, Judd Dayton purchased 18,097 shares of Lifevantage stock. The shares were purchased at an average price of $4.63 per share, with a total value of $83,789.11.
• On Thursday, February 26th, Judd Dayton acquired 4,600 shares of Lifevantage stock. The stock was purchased at an average cost of $4.58 per share, for a total transaction of $21,068.00.

Lifevantage Stock Performance

Shares of LFVN traded down $0.13 during mid-day trading on Monday, hitting $4.52. 155,943 shares of the stock were exchanged, compared to its average volume of 238,601. The company has a market cap of $57.82 million, a PE ratio of 7.53 and a beta of 0.33. Lifevantage Corporation has a 52-week low of $3.90 and a 52-week high of $17.64. The firm has a 50-day moving average of $5.64 and a two-hundred day moving average of $7.92.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.07). Lifevantage had a return on equity of 29.59% and a net margin of 3.74%.The business had revenue of $48.93 million during the quarter, compared to the consensus estimate of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.045 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.18 dividend on an annualized basis and a dividend yield of 4.0%. Lifevantage’s dividend payout ratio (DPR) is presently 30.00%.

Analyst Ratings Changes

Several research firms have recently weighed in on LFVN. Wall Street Zen downgraded Lifevantage from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Lake Street Capital reissued a “buy” rating on shares of Lifevantage in a research note on Thursday, February 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research note on Monday, December 29th. Finally, Loop Capital set a $5.00 price objective on shares of Lifevantage in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $5.00.

Institutional Trading of Lifevantage

Institutional investors and hedge funds have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey bought a new position in Lifevantage during the 2nd quarter worth about $31,000. JPMorgan Chase & Co. raised its holdings in shares of Lifevantage by 870.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after purchasing an additional 4,499 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Lifevantage in the 2nd quarter worth approximately $76,000. BNP Paribas Financial Markets boosted its stake in shares of Lifevantage by 2,555.8% during the second quarter. BNP Paribas Financial Markets now owns 6,135 shares of the company’s stock valued at $80,000 after purchasing an additional 5,904 shares in the last quarter. Finally, Cubist Systematic Strategies LLC bought a new position in shares of Lifevantage during the first quarter valued at approximately $97,000. 35.32% of the stock is currently owned by institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.